Figure 5.
Effects of peptide Nox2 inhibition on skeletal muscle and body mass. (A) Body mass for ambulatory controls (CON), hindlimb unloaded + scrambled peptide (HU), and HU + gp91ds-tat (HUG). (B) Soleus mass means are. (C) Plantar flexor mass/body mass ratio. (a) designates significantly different means than CON; (b) represents a significance difference vs. HU.